Risk factors associated with disease severity and length of hospital stay in COVID-19 patients

Author:

Liu Xiaofan,Zhou Hong,Zhou Yilu,Wu Xiaojun,Zhao Yang,Lu Yang,Tan Weijun,Yuan Mingli,Ding Xuhong,Zou Jinjing,Li Ruiyun,Liu Hailing,Ewing Rob M.,Hu Yi,Nie Hanxiang,Wang Yihua

Funder

Key Project of Science and Technology

Medical Research Council

University of Southampton

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference10 articles.

1. Wuhan and hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources;Zhang;J Infect,2020

2. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet,2020

3. Dysregulation of immune response in patients with COVID-19 in Wuhan, China;Qin;Clin Infect Dis Off Publ Infect Dis Soc Am,2020

4. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by Olmesartan, an angiotensin ii receptor blocker;Furuhashi;Am J Hypertens,2015

5. Effect of angiotensin-converting enzyme inhibition and angiotensin ii receptor blockers on cardiac angiotensin-converting enzyme 2;Ferrario;Circulation,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3